Media

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. 

Hologic is committed to establishing and maintaining strong relationships with the media. This site contains useful information about our Company, including news releases, video and image galleries, and upcoming events.  Please contact us for additional information or questions.  

Recent News
Oct 17, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser...

Oct 11, 2017

London, UK October 11, 2017 - New survey results released today highlight the considerable impact and lack of awareness of heavy periods, which affect one in five women. That’s over 4 million...

Oct 5, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on...

Oct 4, 2017

Hologic, Inc. (NASDAQ: HOLX) announced today that it has priced its previously announced private offering of $350 million aggregate principal amount of 4.375% senior notes due 2025 at an issue...

Oct 4, 2017

MARLBOROUGH, Mass., October 4, 2017 – A new study found that women with symptoms of preterm labor who were discharged from the hospital without a fetal fibronectin (fFN) test were more likely to...

More ›

Featured Video